作者: Christina Tatsi , Constantine A. Stratakis
DOI: 10.1007/S11154-019-09534-8
关键词:
摘要: Aggressive pituitary tumors (APTs) represent rare adenomas (PAs) with local invasion of surrounding tissues, increased risk for multiple recurrence, rapid tumor growth, or resistance to standard therapies. The most common APTs in children and adolescents are giant prolactinomas somatotropinomas. Few cases Crooke’s cell adenomas, silent corticotroph carcinomas have also been reported the literature. Pediatric patients have higher harboring germline genetic defects, commonly MEN1 AIP genes. Since certain defects confer a more aggressive behavior to PAs, testing should be considered young onset positive family history. management pediatric involves usually a combination therapies (surgical, medical, radiation). Newer agents, such as temozolomide, used few promising results. In elderly, PAs non-functioning. Their often poses dilemmas given coexistence age-related comorbidities. However, surgical treatment temozolomide seem safe well tolerated elderly patients.